When GLP-1 levels rise, the body releases insulin, slows stomach emptying, and signals fullness to the brain
FDA-approved uses Indications vary by compound and product: type 2 diabetes (most products), chronic weight management (Wegovy, Saxenda, Zepbound), cardiovascular risk reduction in type 2 diabetes (Ozempic, Trulicity, Victoza, Rybelsus), and obstructive sleep apnea in adults with obesity (Zepbound, December 2024)
Inconsistent Use For GLP-1 drugs to be effective, they need to be taken consistently
Cognitive symptoms are easily attributed to other causes
The biggest benefit is convenience for patients who dislike needles
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Mao T., Zhang C., Yang S., Bi Y., Li M., Yu J